Quid est "Clara"?
Animal non fert mutationem. Morbi non lacus et non consequentes.
Equus Androgen Insensibilitas Syndrome In Generosos Variantes 2 (AIS-T2)
The Androgen Insensitivity Syndrome (AIS) Thoroughbred Variant 2 DNA test is a vital tool for horse breeders and veterinarians. This genetic test identifies carriers of AIS, a condition affecting male horses' development despite normal XY chromosomes. Early detection through the AIS Thoroughbred Variant 2 test helps prevent breeding affected stallions, ensuring healthier offspring and maintaining breed integrity. Utilizing this DNA test supports informed breeding decisions and promotes the overall well-being of Thoroughbred horses. Stay ahead in equine genetics by incorporating the AIS Thoroughbred Variant 2 test into your breeding program today. Accurate and reliable, this test is essential for responsible Thoroughbred management.
Abbreviation: AIS-T2
Mutationem examinare: AR c.2132C/T
hereditas : X-Linked Recessive
Acronym
AIS-T2
Observata frequency
Fusce severitatem
Fusce class
Endocrine Morbis
Analyzed mutationem
AR c.2132C/T
p.(A711V)
p.(A711V)
Modus hereditatis
X-Linked Recessive (Complete)
Summarium Test:
The DNA test for Androgen Insensitivity Syndrome in Thoroughbred Variant 2 (AIS) helps identify horses carrying a genetic mutation that affects sexual development. AIS causes affected horses, typically genetically male, to develop female characteristics despite having XY chromosomes. This condition can impact fertility and breeding decisions in Thoroughbred populations. Early detection through DNA testing allows breeders to make informed choices and manage affected horses appropriately. Overall, the AIS test is a valuable tool for maintaining the health and integrity of Thoroughbred bloodlines.
Praesto ex iumentis: Basic
Hoc DNA test incipiens a nostris includitur sarcina Basic - et etiam pars sarcinae Basic, Standard, Advanced, Complete.
Visum DNA Test sarcinas →Elige sarcinam quae maxime aptat admissura vel sanitatis militarium animalium tuorum.
Introduction to Androgen Insensitivity Syndrome in Thoroughbred Variant 2
Androgen Insensitivity Syndrome (AIS) is a genetic condition that affects the development of sexual characteristics in individuals with XY chromosomes. In horses, particularly in the Thoroughbred breed, a specific variant known as Thoroughbred Variant 2 has been identified. This condition can have significant implications for horse breeding and performance.
Genetic Basis of AIS
AIS is caused by mutations in the androgen receptor gene, which results in a lack of response to androgens, the hormones responsible for male sexual development. In Thoroughbred Variant 2, the genetic mutation manifests in a manner that affects the horse's reproductive system and secondary sexual characteristics. Horses with this syndrome may appear externally female but possess XY chromosomes and internal male reproductive structures.
Clinical Manifestations
Horses affected by Thoroughbred Variant 2 typically display a range of clinical signs. These may include an absence of typical male reproductive organs, the presence of underdeveloped or abnormal genitalia, and a lack of behavioral traits typically associated with stallions. As a result, these horses may not be suitable for breeding purposes, leading to ethical and practical considerations in equine management.
Impact on Breeding and Performance
The presence of AIS in Thoroughbreds can significantly impact breeding programs. Understanding the genetic status of potential breeding stock is crucial for maintaining the integrity and quality of the breed. Horses identified as carriers of the AIS variant may be excluded from breeding to prevent the propagation of the condition, thus ensuring that the lineage remains strong and healthy.
conclusio
Androgen Insensitivity Syndrome in Thoroughbred Variant 2 is a complex genetic condition that poses unique challenges for horse owners and breeders. By understanding the genetic underpinnings and clinical manifestations of this syndrome, stakeholders can make informed decisions that promote the health and viability of Thoroughbred horses. Ongoing research and genetic testing are essential for advancing knowledge and management practices related to AIS.
Genus agnitum pro experimento Androgen Insensibilitas Syndrome In Generosos Variantes 2 (AIS-T2)
- Thoroughbred
🧬 Interpretation of genotypes AIS-T2
Genotype
Status
🟡 N/N
Non tabellarius - No Risk
❌ ♂ N/AIS-T2
Affectus - In Risk
🟡 ♀ N/AIS-T2
Carrier - No Risk
❌ AIS-T2/AIS-T2
Affectus - In Risk
FAQ: interpretatio intellectus
Estne "Carrier" gravis?
No. Animal fere sanum est sed mutationem suum transmittere potest soboles.
Quid si animal "Affectus"?
Mutata duo exemplaria Fert. Fusce signa expectata fretus morbi. Ut non dictum est.
Quare differentiae sunt inter masculinum vel feminam?
Quidam morbi sexus coniuncti sunt, ita eorum expressio variatur secundum quod sexus animalis.
Praedico fetus
N/N (non-tabellarius)
N/AIS-T2 (Portitorem)
AIS-T2/AIS-T2 (affectus)
DNA Test FAQ
Quid haec DNA test deprehendere?
This DNA test detects the mutation associated with Androgen Insensitivity Syndrome In Thoroughbred Variant 2 (AIS-T2) in order to identify clear, carrier, or at-risk animals.
Cur temptas fetum animal?
DNA probatio adiuvat eculis consilium tutius ingenuorum ingenuorum et periculum transmittendi mutationem in posteros minuendi.
Quis est modus hereditatis huius probationis?
The inheritance mode reported for this test is X-Linked Recessive.
Quae mutatio in hoc experimento resolvitur?
This test analyses the mutation AR c.2132C/T.
Estne tabellarius animal necessario affici?
Non necessario. Interpretatio ab hereditate exemplaris et genotypi inde dependet.
References
Villagomez Daniel A F, Welsford Eastman G, King W Allan, Revay Tamas. Androgen Receptor Gene Variants in New Cases of Equine Androgen Insensitivity Syndrome. Genes (Basel). 2020 Jan 10;11(1):78. doi: 10.3390/genes11010078.